Hypertension 2020 - Market Analysis

Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors. According to Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is reckoned for $23,849.39 Million in 2017 and is estimated to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Hypertension is a chronic disease, which means that a patient could need to require medications a day for the rest of his/her life. [...]the demand for anti-hypertensive medication is property and can increase with a rise within the variety of target patients.